NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 266 filers reported holding NOVOCURE LTD in Q2 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $5,524,545 | -55.3% | 322,507 | -59.2% | 0.01% | -55.0% |
| Q1 2024 | $12,353,327 | +6.9% | 790,360 | +2.1% | 0.02% | -9.1% |
| Q4 2023 | $11,553,297 | +153.2% | 773,831 | +919.7% | 0.02% | +10.0% |
| Q1 2023 | $4,563,724 | -11.1% | 75,885 | +11.0% | 0.02% | -50.0% |
| Q4 2021 | $5,134,000 | -79.7% | 68,385 | -40.0% | 0.04% | -86.1% |
| Q2 2021 | $25,289,000 | +915.2% | 114,007 | +504.9% | 0.29% | +620.0% |
| Q1 2021 | $2,491,000 | -63.3% | 18,846 | -83.5% | 0.04% | -60.0% |
| Q2 2020 | $6,784,000 | +1404.2% | 114,408 | +1608.6% | 0.10% | +426.3% |
| Q1 2020 | $451,000 | – | 6,696 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |